InvestorsHub Logo
Post# of 316446
Next 10
Followers 364
Posts 113761
Boards Moderated 5
Alias Born 12/28/2000

Re: None

Thursday, 04/04/2024 9:28:40 AM

Thursday, April 04, 2024 9:28:40 AM

Post# of 316446
EFTR down 78% EFFECTOR Therapeutics said Thursday that it won't be moving forward with development of its tomivosertib lung cancer treatment after phase 2 data showed no positive trend.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.